HIV :: FDA approves new HIV drug raltegravir tablets

The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

Sleep :: Modafinil is effective in treating excessive sleepiness

A study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM) finds that modafinil is well-tolerated in the treatment of excessive sleepiness associated with disorders of sleep and wakefulness such as shift work sleep disorder, obstructive sleep apnea (OSA) and narcolepsy, and does not affect cardiovascular or sleep parameters.

Health :: 2 studies highlight the risks and significant health-care costs of NSAIDs injury

New studies highlight the risks and significant health care costs of GI injury and bleeding from the use of NSAIDs. According to a survey conducted at Eastern Virginia Medical School, 22 percent of respondents did not think NSAIDs were important to mention to their doctor, revealing a common misperception about these over-the-counter remedies.

Alzheimer’s Disease :: New blood test to diagnose Alzheimer’s Disease

A team of international researchers reported they have identified a group of cell-signaling proteins found in blood that serve as a unique “voiceprint” that can not only be used to diagnose Alzheimer’s disease, but also classify and predict presymptomatic individuals who will eventually develop the memory-robbing disorder.

Asthma :: Even occasional use of spray cleaners may cause asthma in adults

Using household cleaning sprays and air fresheners as little as once a week can raise the risk of developing asthma in adults, say researchers in Europe. Such products have been associated with increased asthma rates in cleaning professionals, but a similar effect in nonprofessional users has never before been shown.